These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24103255)

  • 41. Comorbidity and correlates of disruptive mood dysregulation disorder in 6-8-year-old children with ADHD.
    Mulraney M; Schilpzand EJ; Hazell P; Nicholson JM; Anderson V; Efron D; Silk TJ; Sciberras E
    Eur Child Adolesc Psychiatry; 2016 Mar; 25(3):321-30. PubMed ID: 26122202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Lifetime Mental Disorders and Subsequent Alcohol and Illicit Drug Use: Results From the National Comorbidity Survey-Adolescent Supplement.
    Conway KP; Swendsen J; Husky MM; He JP; Merikangas KR
    J Am Acad Child Adolesc Psychiatry; 2016 Apr; 55(4):280-8. PubMed ID: 27015718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Israel Survey of Mental Health among Adolescents: prevalence of attention-deficit/hyperactivity disorder, comorbidity, methylphenidate use, and help-seeking patterns.
    Farbstein I; Mansbach-Kleinfeld I; Auerbach JG; Ponizovsky AM; Apter A
    Isr Med Assoc J; 2014 Sep; 16(9):568-73. PubMed ID: 25351015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes.
    Upadhyay N; Chen H; Mgbere O; Bhatara VS; Aparasu RR
    Subst Use Misuse; 2017 Aug; 52(10):1266-1274. PubMed ID: 28323525
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.
    Kessler RC; Berglund P; Demler O; Jin R; Merikangas KR; Walters EE
    Arch Gen Psychiatry; 2005 Jun; 62(6):593-602. PubMed ID: 15939837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Literacy difficulties and psychiatric disorders: evidence for comorbidity.
    Carroll JM; Maughan B; Goodman R; Meltzer H
    J Child Psychol Psychiatry; 2005 May; 46(5):524-32. PubMed ID: 15845132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R).
    Kessler RC; Birnbaum H; Bromet E; Hwang I; Sampson N; Shahly V
    Psychol Med; 2010 Feb; 40(2):225-37. PubMed ID: 19531277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
    Froehlich TE; Lanphear BP; Epstein JN; Barbaresi WJ; Katusic SK; Kahn RS
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):857-64. PubMed ID: 17768285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics and comorbidity of ADHD sib pairs in the Central Valley of Costa Rica.
    Schuler J; Weiss NT; Chavira DA; McGough JJ; Berrocal M; Sheppard B; Vaglio E; Fournier E; Herrera LD; Mathews CA
    Compr Psychiatry; 2012 May; 53(4):379-86. PubMed ID: 21696714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.
    Kessler RC; Adler LA; Barkley R; Biederman J; Conners CK; Faraone SV; Greenhill LL; Jaeger S; Secnik K; Spencer T; Ustün TB; Zaslavsky AM
    Biol Psychiatry; 2005 Jun; 57(11):1442-51. PubMed ID: 15950019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Food insecurity and mental disorders in a national sample of U.S. adolescents.
    McLaughlin KA; Green JG; Alegría M; Jane Costello E; Gruber MJ; Sampson NA; Kessler RC
    J Am Acad Child Adolesc Psychiatry; 2012 Dec; 51(12):1293-303. PubMed ID: 23200286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome.
    Hirschtritt ME; Lee PC; Pauls DL; Dion Y; Grados MA; Illmann C; King RA; Sandor P; McMahon WM; Lyon GJ; Cath DC; Kurlan R; Robertson MM; Osiecki L; Scharf JM; Mathews CA;
    JAMA Psychiatry; 2015 Apr; 72(4):325-33. PubMed ID: 25671412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects.
    Biederman J; Kwon A; Aleardi M; Chouinard VA; Marino T; Cole H; Mick E; Faraone SV
    Am J Psychiatry; 2005 Jun; 162(6):1083-9. PubMed ID: 15930056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attention-deficit/hyperactivity disorder symptoms and suicidal behavior in adult psychiatric outpatients.
    Stickley A; Tachimori H; Inoue Y; Shinkai T; Yoshimura R; Nakamura J; Morita G; Nishii S; Tokutsu Y; Otsuka Y; Egashira K; Inoue M; Kubo T; Tesen H; Takashima N; Tominaga H; Koyanagi A; Kamio Y
    Psychiatry Clin Neurosci; 2018 Sep; 72(9):713-722. PubMed ID: 29845681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender differences among children with DSM-IV ADHD in Australia.
    Graetz BW; Sawyer MG; Baghurst P
    J Am Acad Child Adolesc Psychiatry; 2005 Feb; 44(2):159-68. PubMed ID: 15689729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the DSM-5 attention-deficit/hyperactivity disorder age-of-onset criterion in the US adolescent population.
    Vande Voort JL; He JP; Jameson ND; Merikangas KR
    J Am Acad Child Adolesc Psychiatry; 2014 Jul; 53(7):736-44. PubMed ID: 24954823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anxiety and disruptive behavior mediate pathways from attention-deficit/hyperactivity disorder to depression.
    Roy A; Oldehinkel AJ; Verhulst FC; Ormel J; Hartman CA
    J Clin Psychiatry; 2014 Feb; 75(2):e108-13. PubMed ID: 24602257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders.
    Ford T; Goodman R; Meltzer H
    J Am Acad Child Adolesc Psychiatry; 2003 Oct; 42(10):1203-11. PubMed ID: 14560170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.